Welcome to LookChem.com Sign In|Join Free
  • or
D-Glutamine, the D-enantiomer of glutamine, is an unnatural isomer of L-Glutamine that is found in human plasma and serves as a source of liberated ammonia. It is a white crystalline powder and can be synthesized enzymatically or obtained from cheeses, wine, and vinegars. D-Glutamine plays a significant role in various biological processes and is used for multiple applications across different industries.

5959-95-5

Post Buying Request

5959-95-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5959-95-5 Usage

Uses

Used in Pharmaceutical Industry:
D-Glutamine is used as a research compound for studying the activity of Glutamine synthetase, an enzyme that is commonly found in the mammalian liver and brain and controls the use of nitrogen in cells. This helps in understanding the role of D-Glutamine in various biological processes and its potential therapeutic applications.
Used in Biomedical Research:
D-Glutamine is used as an experimental compound to investigate its role in conferring protection against acetaldehyde-induced disruption of barrier function in Caco-2 cell monolayers. This research contributes to the understanding of D-Glutamine's potential protective effects on cellular barriers and its implications in maintaining cellular integrity.
Used in Food Industry:
D-Glutamine can be found in various fermented food products such as cheeses, wine, and vinegars. Its presence in these products may contribute to their unique flavors and characteristics, making it an important component in the food industry.
Used in Analytical Chemistry:
As a white crystalline powder, D-Glutamine can be used as a reference compound in analytical chemistry for the identification and quantification of amino acids in various samples, including biological tissues and fluids.

Biochem/physiol Actions

Glutamine forms the central metabolite in amino acid transamination via a-ketoglutarate and glutamic acid. This amino acid is metabolized by different enzymes, such as glutaminase, present in liver, and glutamine synthetase, present in skeletal muscle. It is produced in the cytoplasm from other amino acids, predominantly from branched-chain amino acids and glutamate. It plays an essential role in ammonia metabolism and detoxification. Its skeletal muscle levels are significantly reduced post trauma, operation and inflammatory states. It servers as a prognostic marker in fatal sepsis during which its skeletal muscle levels are decreased by 90%.

Check Digit Verification of cas no

The CAS Registry Mumber 5959-95-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,9,5 and 9 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5959-95:
(6*5)+(5*9)+(4*5)+(3*9)+(2*9)+(1*5)=145
145 % 10 = 5
So 5959-95-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m1/s1

5959-95-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (G0278)  D-Glutamine  >98.0%(T)

  • 5959-95-5

  • 1g

  • 770.00CNY

  • Detail
  • TCI America

  • (G0278)  D-Glutamine  >98.0%(T)

  • 5959-95-5

  • 5g

  • 2,490.00CNY

  • Detail

5959-95-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name D-glutamine

1.2 Other means of identification

Product number -
Other names 2-amino-4-carbamoylbutanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5959-95-5 SDS

5959-95-5Synthetic route

D-glutamic acid-5-hydrazide
19427-23-7

D-glutamic acid-5-hydrazide

D-Glutamin
5959-95-5

D-Glutamin

Conditions
ConditionsYield
With ethanol; nickel
N2-(toluene-4-sulfonyl)-D-glutamine
42749-49-5

N2-(toluene-4-sulfonyl)-D-glutamine

D-Glutamin
5959-95-5

D-Glutamin

Conditions
ConditionsYield
With ammonia; sodium
DL-5-carbamylethylhydantoin
69489-32-3

DL-5-carbamylethylhydantoin

D-Glutamin
5959-95-5

D-Glutamin

Conditions
ConditionsYield
With potassium phosphate buffer; Pseudomonas sp. AJ-11220 In various solvent(s) at 30℃; for 2h;
With potassium phosphate buffer; Pseudomonas sp. AJ-11220 In various solvent(s) at 30℃; for 2h; pH 8.0; enzymatic reaction;
Conditions
ConditionsYield
With (2R,3R,11R,12R)-(+)-18-crown-6-2,3,11,12-tetracarbonic acid
With R-(3,3'-dibromo-1,1'-binaphthyl)-20-crown-6 coated C18 silica gel column at 25℃; pH=2; Resolution of racemate;
benzeneacetic acid methyl ester
101-41-7

benzeneacetic acid methyl ester

A

D-Glutamin
5959-95-5

D-Glutamin

B

α-N-phenylacetyl-L-glutamine
28047-15-6

α-N-phenylacetyl-L-glutamine

Conditions
ConditionsYield
With sodium hydroxide; E. coli penicillin-G acylase F24A mutant at 25℃; pH=9.0;
D-Glutamic acid
6893-26-1

D-Glutamic acid

D-Glutamin
5959-95-5

D-Glutamin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: HCl
2: H2O; N2H4+H2O
3: Raney nickel; aqueous ethanol
View Scheme
(R)-2-amino-5-methoxy-5-oxopentanoic acid
6461-04-7

(R)-2-amino-5-methoxy-5-oxopentanoic acid

D-Glutamin
5959-95-5

D-Glutamin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: H2O; N2H4+H2O
2: Raney nickel; aqueous ethanol
View Scheme
5-oxo-1-(toluene-4-sulfonyl)-D-proline
882861-84-9

5-oxo-1-(toluene-4-sulfonyl)-D-proline

D-Glutamin
5959-95-5

D-Glutamin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: water; NH3
2: sodium; liquid NH3
View Scheme
1-(4'-methylbenzenesulfonyl)-5-oxopyrrolidine-2-carboxylic acid
21957-65-3

1-(4'-methylbenzenesulfonyl)-5-oxopyrrolidine-2-carboxylic acid

D-Glutamin
5959-95-5

D-Glutamin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: brucine
2: water; NH3
3: sodium; liquid NH3
View Scheme
(PPh3)2 PdCl2

(PPh3)2 PdCl2

1-acetamido-3-carbamoylpropene

1-acetamido-3-carbamoylpropene

2-(2-isopropyl-5-methylcyclohexyloxy)ethanol

2-(2-isopropyl-5-methylcyclohexyloxy)ethanol

D-Glutamin
5959-95-5

D-Glutamin

Conditions
ConditionsYield
With CO In tetrahydrofuran; hydrogenchloride
1-acetamido-3-carbamoylpropene

1-acetamido-3-carbamoylpropene

2-(2-isopropyl-5-methylcyclohexyloxy)ethanol

2-(2-isopropyl-5-methylcyclohexyloxy)ethanol

D-Glutamin
5959-95-5

D-Glutamin

Conditions
ConditionsYield
With CO; (PPh3)2PdCl2 In tetrahydrofuran; hydrogenchloride
jagaricin
1422729-34-7

jagaricin

A

D-allo-threonine
24830-94-2

D-allo-threonine

B

(2S,3S)-2-amino-3-hydroxybutanoic acid
28954-12-3

(2S,3S)-2-amino-3-hydroxybutanoic acid

C

L-threonine
72-19-5

L-threonine

D

D-Glutamin
5959-95-5

D-Glutamin

E

(R)-3-hydroxytetradecanoic acid
28715-21-1

(R)-3-hydroxytetradecanoic acid

F

dehydrobutyrine
20748-08-7

dehydrobutyrine

G

tyrosine
556-02-5

tyrosine

H

glycine
56-40-6

glycine

I

L-histidine
71-00-1

L-histidine

Conditions
ConditionsYield
With hydrogenchloride; phenol In water at 105℃; Reagent/catalyst;
Conditions
ConditionsYield
With fatty acid photodecarboxylase from Chlorella variabilis NC64A/G462Y mutant In aq. phosphate buffer; dimethyl sulfoxide at 20℃; for 12h; pH=8.5; Catalytic behavior; Reagent/catalyst; Irradiation; Resolution of racemate; Enzymatic reaction; enantioselective reaction;n/a
D-Glutamin
5959-95-5

D-Glutamin

(R)-N-(2-benzoyl-4-chlorophenyl)-2-[3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]azepine-4-yl]acetamide

(R)-N-(2-benzoyl-4-chlorophenyl)-2-[3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]azepine-4-yl]acetamide

nickel(II) acetate tetrahydrate
6018-89-9

nickel(II) acetate tetrahydrate

C42H33ClN4NiO4

C42H33ClN4NiO4

Conditions
ConditionsYield
With potassium carbonate In methanol at 60 - 70℃; for 3h; diastereoselective reaction;93%
D-Glutamin
5959-95-5

D-Glutamin

3-carbamoyl-1-(2,4-dinitrophenyl)pyridinium chloride
53406-00-1

3-carbamoyl-1-(2,4-dinitrophenyl)pyridinium chloride

C11H14N3O4(1+)

C11H14N3O4(1+)

Conditions
ConditionsYield
With triethylamine In methanol at 20℃; for 48h;88.2%
D-Glutamin
5959-95-5

D-Glutamin

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

(2R)-5-amino-2-(tert-butoxycarbonylamino)-5-oxo-pentanoic acid
61348-28-5

(2R)-5-amino-2-(tert-butoxycarbonylamino)-5-oxo-pentanoic acid

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 0℃; for 1h;86%
D-Glutamin
5959-95-5

D-Glutamin

benzyl bromide
100-39-0

benzyl bromide

(R)-(+)-N,N-dibenzylglutamine benzyl ester

(R)-(+)-N,N-dibenzylglutamine benzyl ester

Conditions
ConditionsYield
With potassium carbonate In water at 20℃; for 240h; benzylation;46%
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 0.833333h;
D-Glutamin
5959-95-5

D-Glutamin

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

2C5H6NO3(1-)*2Ba(2+)*CHO2(1-)*NO3(1-)

2C5H6NO3(1-)*2Ba(2+)*CHO2(1-)*NO3(1-)

Conditions
ConditionsYield
With barium(II) nitrate In water at 100℃; for 72h;0.78%
(R)-2-bromopropionyl chloride
7148-74-5, 22592-73-0, 71425-59-7, 52152-04-2

(R)-2-bromopropionyl chloride

D-Glutamin
5959-95-5

D-Glutamin

N2-(2-bromo-propionyl)-glutamine

N2-(2-bromo-propionyl)-glutamine

Conditions
ConditionsYield
With alkali ;
(R)-2-Bromo-4-methyl-pentanoyl chloride
28659-88-3, 59960-79-1, 104420-63-5

(R)-2-Bromo-4-methyl-pentanoyl chloride

D-Glutamin
5959-95-5

D-Glutamin

N2-(2-bromo-4-methyl-valeryl)-glutamine

N2-(2-bromo-4-methyl-valeryl)-glutamine

Conditions
ConditionsYield
With alkali ;
D-Glutamin
5959-95-5

D-Glutamin

chloroacetyl chloride
79-04-9

chloroacetyl chloride

N2-chloroacetyl-glutamine
13139-62-3

N2-chloroacetyl-glutamine

Conditions
ConditionsYield
With sodium hydroxide; diethyl ether chloroacetyl-d-glutamine;
D-Glutamin
5959-95-5

D-Glutamin

phenylacetyl chloride
103-80-0

phenylacetyl chloride

α-N-phenylacetyl-L-glutamine
28047-15-6

α-N-phenylacetyl-L-glutamine

Conditions
ConditionsYield
With sodium hydrogencarbonate
D-Glutamin
5959-95-5

D-Glutamin

telocinobufagin 3-hemisuberate p-nitrophenyl ester
75090-28-7

telocinobufagin 3-hemisuberate p-nitrophenyl ester

telocinobufagin 3-suberoyl-D-glutamine ester
75104-51-7

telocinobufagin 3-suberoyl-D-glutamine ester

Conditions
ConditionsYield
In pyridine; water for 5h; Ambient temperature;2 mg
D-Glutamin
5959-95-5

D-Glutamin

marinobufagin 3-hemisuberate p-nitrophenyl ester
71156-90-6

marinobufagin 3-hemisuberate p-nitrophenyl ester

marinobufagin 3-suberoyl-D-glutamine ester
71156-91-7

marinobufagin 3-suberoyl-D-glutamine ester

Conditions
ConditionsYield
In pyridine; water for 1h; Ambient temperature;10 mg
D-Glutamin
5959-95-5

D-Glutamin

(N-benzyloxycarbonyl)-L-alanine N-hydroxysuccinimide ester
3401-36-3

(N-benzyloxycarbonyl)-L-alanine N-hydroxysuccinimide ester

Cbz-L-Ala-D-Gln
74842-54-9

Cbz-L-Ala-D-Gln

Conditions
ConditionsYield
With triethylamine; 1-amino-3-(dimethylamino)propane 1.) THF, H2O, 4 deg C, 24 h, 2.) THF, H2O, 1 h; Yield given. Multistep reaction;
D-Glutamin
5959-95-5

D-Glutamin

γ-OSu-N-Z-L-Glu-OBzl
34897-67-1

γ-OSu-N-Z-L-Glu-OBzl

benzyloxycarbonyl-α-benzyl-γ-L-glutamyl-D-glutamine

benzyloxycarbonyl-α-benzyl-γ-L-glutamyl-D-glutamine

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide for 24h; Ambient temperature; Yield given;
D-Glutamin
5959-95-5

D-Glutamin

Oγ-benzyl-Nα-benzyloxycarbonylglutamic acid succinimidyl ester
67413-34-7

Oγ-benzyl-Nα-benzyloxycarbonylglutamic acid succinimidyl ester

benzyloxycarbonyl-γ-benzyl-α-L-glutamyl-D-glutamine
75898-60-1

benzyloxycarbonyl-γ-benzyl-α-L-glutamyl-D-glutamine

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide for 24h; Ambient temperature; Yield given;
D-Glutamin
5959-95-5

D-Glutamin

γ-D-glutamyl-D-glutamine

γ-D-glutamyl-D-glutamine

Conditions
ConditionsYield
With Tris buffer (pH: 8.8) at 37℃; for 2h; transamidase from Bacillus natto; Yield given;
With γ-glutamyltransferase from Bacillus subtilis In aq. buffer at 22℃; for 24h; pH=8.5; pH-value; Enzymatic reaction;
D-Glutamin
5959-95-5

D-Glutamin

dl-α-bromo-isocaproic acid chloride

dl-α-bromo-isocaproic acid chloride

N2-(2-bromo-4-methyl-valeryl)-glutamine

N2-(2-bromo-4-methyl-valeryl)-glutamine

Conditions
ConditionsYield
With alkali ;
D-Glutamin
5959-95-5

D-Glutamin

l-α-bromo-propionyl chloride

l-α-bromo-propionyl chloride

N2-(2-bromo-propionyl)-glutamine

N2-(2-bromo-propionyl)-glutamine

Conditions
ConditionsYield
With alkali ;
α-ketoglutaric acid
328-50-7

α-ketoglutaric acid

D-Glutamin
5959-95-5

D-Glutamin

N2-(1-carboxyethyl)-D-glutamine

N2-(1-carboxyethyl)-D-glutamine

Conditions
ConditionsYield
With sodium cyanoborohydride; acetic acid In water pH=6.0 - 6.8;
D-Glutamin
5959-95-5

D-Glutamin

carbonic acid 2,5-dioxopyrrolidin-1-yl ester 4-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)benzyl ester
556050-48-7

carbonic acid 2,5-dioxopyrrolidin-1-yl ester 4-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)benzyl ester

(R)-4-Carbamoyl-2-[4-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-octyl)-benzyloxycarbonylamino]-butyric acid

(R)-4-Carbamoyl-2-[4-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-octyl)-benzyloxycarbonylamino]-butyric acid

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran; water at 25℃;
undec-10-enoyl chloride
38460-95-6

undec-10-enoyl chloride

D-Glutamin
5959-95-5

D-Glutamin

(R)-4-Carbamoyl-2-undec-10-enoylamino-butyric acid

(R)-4-Carbamoyl-2-undec-10-enoylamino-butyric acid

Conditions
ConditionsYield
With sodium carbonate In tetrahydrofuran at 20℃;
quinolin-2-ylmethylbromide
5632-15-5

quinolin-2-ylmethylbromide

D-Glutamin
5959-95-5

D-Glutamin

C25H24N4O3

C25H24N4O3

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water
D-Glutamin
5959-95-5

D-Glutamin

(R)-4-Carbamoyl-2-undecanoylamino-butyric acid

(R)-4-Carbamoyl-2-undecanoylamino-butyric acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. Na2CO3 / tetrahydrofuran / 20 °C
2: H2 / Pd/C / methanol / 20 °C / atmospheric pressure
View Scheme
D-Glutamin
5959-95-5

D-Glutamin

(R)-2-((S)-2-Amino-propionylamino)-4-carbamoyl-butyric acid ethyl ester

(R)-2-((S)-2-Amino-propionylamino)-4-carbamoyl-butyric acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) Et3N, 2.) dimethylaminopropylamine / 1.) THF, H2O, 4 deg C, 24 h, 2.) THF, H2O, 1 h
2: 1.) aq. Cs2CO3 / 1.) THF, 2.) DMF, RT, 48 h
3: H2, HOAc, 1 N HCl / 5percent Pd/C / 2 h / 760 Torr
View Scheme

5959-95-5Relevant academic research and scientific papers

Single-Cell-Based Screening and Engineering of d -Amino Acid Amidohydrolases Using Artificial Amidophenol Substrates and Microbial Biosensors

An, Jung-Ung,Kim, Haseong,Kwon, Kil Koang,Lee, Dae-Hee,Lee, Hyewon,Lee, Jin-Young,Lee, Seung-Goo,Park, Sung Hyun,Rha, Eugene,Yeom, Soo-Jin

, p. 1203 - 1211 (2022/01/27)

Enantiomerically pure d-amino acids are important intermediates as chiral building blocks for peptidomimetics and semisynthetic antibiotics. Here, a transcriptional factor-based screening strategy was used for the rapid screening of d-stereospecific amino acid amidase via an enzyme-specific amidophenol substrate. We used a d-threonine amidophenyl derivative to produce 2-aminophenol that serves as a putative enzyme indicator in the presence of d-threonine amidases. Comparative analyses of known bacterial species indicated that several Bacillus strains produce amidase and form putative indicators in culture media. The estimated amidase was cloned and subjected to rapid directed evolution through biosensor cells. Consequently, we characterized the F119A mutation that significantly improved the catalytic activity toward d-alanine, d-threonine, and d-glutamate. Its beneficial effects were confirmed by higher conversions and recurrent applications of the mutant enzyme, compared to the wild-type. This study showed that rapid directed evolution with biosensors coupled to designed substrates is useful to develop biocatalytic processes.

A novel strategy for efficient chemoenzymatic synthesis of D-glutamine using recombinant Escherichia coli cells

Du, Qinglin,Zhang, Xiangyang,Pan, Xinru,Zhang, Hongjuan,Yang, Yu-Shun,Liu, Junzhong,Jiao, Qingcai

, (2020/06/17)

D-glutamine is a D type stereoisomer of glutamine which is involved in many metabolic processes. Seeking lower-cost and industrially scalable approaches for the synthesis of D-glutamine is very valuable both in academic career and potential applications. Herein, we developed a novel efficient chemoenzymatic strategy for producing D-glutamine. Initially, DL-glutamine was chemically prepared with cheap and accessible DL-glutamic acid as raw material. Subsequently, the L-glutamine among the racemic mixture was selectively hydrolyzed to L-glutamic acid by Escherichia coli whole-cell system which expressed L-aminopeptidase D-Ala-esterase/amidase (DmpA) from Ochrobactrum anthropi. The left D-glutamine was obtained by isoelectric point precipitation with 70% of the theoretical yield. Furthermore, we optimized enzymatic resolution conditions to determine the optimum parameters as pH 8, 30 °C, 0.1% (v/v) Triton X-100, and 1 mM Mn2+. These results suggested that our strategy might be potentially usable for the synthesis of D-glutamine in industrial productions.

Light-Driven Kinetic Resolution of α-Functionalized Carboxylic Acids Enabled by an Engineered Fatty Acid Photodecarboxylase

Xu, Jian,Hu, Yujing,Fan, Jiajie,Arkin, Mamatjan,Li, Danyang,Peng, Yongzhen,Xu, Weihua,Lin, Xianfu,Wu, Qi

supporting information, p. 8474 - 8478 (2019/05/24)

Chiral α-functionalized carboxylic acids are valuable precursors for a variety of medicines and natural products. Herein, we described an engineered fatty acid photodecarboxylase (CvFAP)-catalyzed kinetic resolution of α-amino acids and α-hydroxy acids, which provides the unreacted R-configured substrates with high yields and excellent stereoselectivity (ee up to 99 %). This efficient light-driven process requires neither NADPH recycling nor prior preparation of esters, which were required in previous biocatalytic approaches. The structure-guided engineering strategy is based on the scanning of large amino acids at hotspots to narrow the substrate binding tunnel. To the best of our knowledge, this is the first example of asymmetric catalysis by an engineered CvFAP.

Chromatographic Resolution of α-Amino Acids by (R)-(3,3'-Halogen Substituted-1,1'-binaphthyl)-20-crown-6 Stationary Phase in HPLC

Wu, Peng,Wu, Yuping,Zhang, Junhui,Lu, Zhenyu,Zhang, Mei,Chen, Xuexian,Yuan, Liming

supporting information, p. 1037 - 1042 (2017/07/25)

Three new chiral stationary phases (CSPs) for high-performance liquid chromatography were prepared from R-(3,3'-halogen substituted-1,1'-binaphthyl)-20-crown-6 (halogen = Cl, Br and I). The experimental results showed that R-(3,3'-dibromo-1,1'-binaphthyl)-20-crown-6 (CSP-1) possesses more prominent enantioselectivity than the two other halogen-substituted crown ether derivatives. All twenty-one α-amino acids have different degrees of separation on R-(3,3'-dibromo-1,1'-binaphthyl)-20-crown-6-based CSP-1 at room temperature. The enantioselectivity of CSP-1 is also better than those of some commercial R-(1,1'-binaphthyl)-20-crown-6 derivatives. Both the separation factors (α) and the resolution (Rs) are better than those of commercial crown ether-based CSPs [CROWNPAK CR(+) from Daicel] under the same conditions for asparagine, threonine, proline, arginine, serine, histidine and valine, which cannot be separated by commercial CR(+). This study proves the commercial usefulness of the R-(3,3'-dibromo-1,1'-binaphthyl)-20-crown-6 chiral stationary phase.

SEPARATING AGENT AND MANUFACTURING METHOD THEREOF

-

Paragraph 0067; 0068; 0069; 0070; 0071; 0072; 0089; 0090, (2015/01/07)

An embodiment of the present invention is a separating agent wherein a group represented by a chemical formula of: or a group represented by a chemical formula of: is introduced on a surface thereof.

SEPARATING AGENT FOR CHROMATOGRAPHY

-

Paragraph 0074; 0075, (2013/08/15)

A separating agent for chromatography is provided that is useful for the separation of specific compounds, e.g., for the optical resolution of amino acids. This separating agent for chromatography provides a higher productivity and contains a crown ether-like cyclic structure and optically active binaphthyl. This separating agent for chromatography containing a crown ether-like cyclic structure and optically active binaphthyl is provided by introducing a substitution group for binding to carrier into a specific commercially available 1,1′-binaphthyl derivative that has substituents at the 2, 2′, 3, and 3′ positions, then introducing a crown ether-like cyclic structure, and subsequently chemically bonding the binaphthyl derivative to the carrier through the substitution group for binding to carrier.

Imaging mass spectrometry and genome mining reveal highly antifungal virulence factor of mushroom soft rot pathogen

Graupner, Katharina,Scherlach, Kirstin,Bretschneider, Tom,Lackner, Gerald,Roth, Martin,Gross, Harald,Hertweck, Christian

supporting information, p. 13173 - 13177 (2013/03/14)

Soft rot diseases caused by a variety of bacteria account for severe losses in agriculture, devastating fruits, vegetables, and cultivated mushrooms. After bacterial infection, often owing to direct contact or transmission by insects, virulence factors and lytic enzymes cause degradation of plant and mushroom tissues, thereby turning crop into mush. In many cases, the chemical mediators of soft rot diseases have remained elusive, as in the long-known mushroom pathogen Janthinobacterium agaricidamnosum. This motile Gram-negative bacterium has been found to be the causative agent of soft rot disease of the cultured button mushroom, Agaricus bisporus. Typical symptoms of the infection are lesions turning into sticky blotches on the cap surface and a complete dissolution of the mushroom within only a few days (Figure 1A, B). We reasoned that knowledge on the causative agent of the soft rot would have a double benefit. Foremost, it could aid in understanding the pathobiology of the mushroom pathogen, which may be a starting point for protective measures. Second, there is an increasing need for novel antifungals, since the incidents of severe and even lethal fungal infections and resistance towards antifungals are on the rise. We hypothesized that mushroom soft rot bacteria could excrete antifungal agents as virulence factors, which might also be active against human pathogens. Herein we report the discovery and full characterization of a highly antifungal virulence factor from the soft rot pathogen Janthinobacterium agaricidamnosum guided by imaging mass spectrometry and genome mining.

Preparation of D-amino acids by enzymatic kinetic resolution using a mutant of penicillin-G acylase from E. coli

Carboni, Chiara,Kierkels, Hans G. T.,Gardossi, Lucia,Tamiola, Kamil,Janssen, Dick B.,Quaedflieg, Peter J. L. M.

, p. 245 - 251 (2007/10/03)

We have demonstrated for the first time that d-glutamine (d-Gln) and d-glutamic acid (d-Glu) can be efficiently obtained in high ee (97% and 90%, respectively) by enzymatic kinetic resolution of d,l-Gln and d,l-Glu. This was achieved by enantioselective conversion of the l-enantiomers to their N-phenylacetyl derivatives in aqueous solution, using a mutant of penicillin-G acylase (PGA) from E. coli and phenylacetic acid methylester as the acyl donor. Kinetic modeling studies suggest that the high ee values obtained are both due to a strong enantiopreference for the l-amino acid in the deacylation step of the covalent enzyme intermediate, as well as to completeness of conversion that is transiently obtained as a result of the distinct preference of the mutant PGA for phenylacetic acid methylester over the N-phenylacetyl-l-amino acid product. For the other amino acids tested (Asn, Asp, and Ser), the highest ee values that were obtained for the remaining d-enantiomer are moderate (50-80%) because of lower enantioselectivity in the enzyme deacylation step and due to less complete conversion of the l-amino acid caused by competition for the active site between the acyl donor and the N-phenylacetyl-l-amino acid that is produced. The results demonstrate that the mutated PGA has great potential for the production of optically active D-amino acids by kinetic resolution.

Analysis of underivatized amino acids and their D/L-enantiomers by sheathless capillary electrophoresis/electrospray ionization-mass spectrometry

Schultz, Casey L.,Moini, Mehdi

, p. 1508 - 1513 (2007/10/03)

Capillary electrophoresis/electrospray ionization-mass spectrometry (CE/ESI-MS) was applied to the analysis of underivatized amino acids and the separation of their D/L-enantiomers. Under full-scan mode, all standard protein amino acids were separated and detected at low-femtomole levels using a 130-cm-long, 20-μm-i.d., 150-μm-o.d. underivatized fused-silica capillary with 1 M formic acid as the background electrolyte. The CE/ESI-MS technique was also applied to the separation of L-arginine from L-canavanine (a close analogue of arginine where the terminal methylene linked to the guanidine group of arginine is replaced by an oxygen atom) in a complex mixture containing all standard protein amino acids. The utility of CE/ESI-MS in the analysis of real-world samples was demonstrated by the identification of two metabolic diseases (PKU and tyrosinemia) through blood analysis with minimal sample preparation. In addition, the on-line separation of 11 underivatized L-amino acids from their D-enantiomers was achieved by using a 30 mM solution of (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid as the background electrolyte.

Compounds for and methods of inhibiting matrix metalloproteinases

-

, (2008/06/13)

The present invention relates to compounds of Formula I that inhibit matrix metalloproteinases and to a method of inhibiting matrix metalloproteinases using the compounds More particularly, the present invention relates to a method of treating diseases in which matrix metalloproteinases are involved such as multiple sclerosis, atherosclerotic plaque rupture, restenosis, aortic aneurysm, heart failure, periodontal disease, corneal ulceration, burns, decubital ulcers, chronic ulcers or wounds, cancer metastasis, tumor angiogenesis, osteoporosis, rheumatoid or osteoarthritis, renal disease, left ventricular dilatation, or other autoimmune or inflammatory diseases dependent upon tissue invasion by leukocytes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5959-95-5